Health Care & Life Sciences » Pharmaceuticals | vTv Therapeutics Inc.

vTv Therapeutics Inc. Cl A | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
36,101.00
41,107.00
22,649.00
54,647.00
23,845
Depreciation, Depletion & Amortization
864.00
501.00
265.00
197.00
218
Other Funds
6,142.00
1,619.00
75,209.00
4,853.00
4,316
Funds from Operations
29,095.00
38,987.00
52,295.00
49,597.00
19,311
Changes in Working Capital
1,684.00
2,041.00
4,086.00
5,037.00
7,545
Net Operating Cash Flow
30,779.00
36,946.00
48,209.00
44,560.00
26,856
Capital Expenditures
33.00
104.00
87.00
57.00
Sale of Fixed Assets & Businesses
334.00
25.00
4.00
32.00
Net Investing Cash Flow
161.00
79.00
83.00
25.00
Issuance/Reduction of Debt, Net
33,413.00
19,200.00
11,794.00
7,500.00
Net Financing Cash Flow
30,913.00
123,644.00
11,794.00
7,500.00
Net Change in Cash
295.00
86,619.00
36,498.00
37,085.00
Free Cash Flow
30,812.00
37,050.00
48,296.00
44,617.00
Net Assets from Acquisitions
140.00
-
-
-
Change in Capital Stock
2,500.00
104,444.00
-
-

About vTv Therapeutics

View Profile
Address
4170 Mendenhall Oaks Parkway
High Point North Carolina 27265
United States
Employees -
Website http://www.vtvtherapeutics.com
Updated 07/08/2019
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.